Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 32326 - 32350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Diclofenac	Approved Investigational Vet Approved	TPD52	7163	upregulated	Diclofenac results in increased expression of TPD52 mRNA	8q21.13	A21681
Diclofenac	Approved Investigational Vet Approved	TXN	7295	upregulated	Diclofenac results in increased expression of TXN mRNA	9q31.3	A22275
Diclofenac	Approved Investigational Vet Approved	TXNIP	10628	upregulated	Diclofenac results in increased expression of TXNIP mRNA	1q21.1	A21015
Diclofenac	Approved Investigational Vet Approved	UGT1A1	54658	upregulated	Diclofenac results in increased expression of UGT1A1 mRNA	2q37.1	A21482
Dicloxacillin	Approved Investigational Vet Approved	CYP3A4	1576	upregulated	Dicloxacillin results in increased expression of CYP3A4 mRNA	7q22.1	A15703
Stavudine	Approved Investigational	ABCB1	5243	upregulated	Stavudine results in increased expression of ABCB1 mRNA	7q21.12	A22284
Stavudine	Approved Investigational	PPARG	5468	downregulated	Stavudine results in decreased expression of PPARG mRNA	3p25.2	A20414
Stavudine	Approved Investigational	UCP2	7351	downregulated	Stavudine results in decreased expression of UCP2 mRNA	11q13	A20414
Stavudine	Approved Investigational	UCP3	7352	downregulated	Stavudine results in decreased expression of UCP3 mRNA	11q13.4	A20414
Zalcitabine	Approved Withdrawn	IL2RA	3559	downregulated	Zalcitabine results in decreased expression of IL2RA mRNA	10p15.1	A22285
Zalcitabine	Approved Withdrawn	TK1	7083	downregulated	Zalcitabine results in decreased expression of TK1 mRNA	17q25.3	A22286
Zalcitabine	Approved Withdrawn	TK2	7084	downregulated	Zalcitabine results in decreased expression of TK2 mRNA	16q21	A22286
Dienogest	Approved Investigational	AKR1C1	1645	downregulated	dienogest results in decreased expression of AKR1C1 mRNA	10p15.1	A22287
Dienogest	Approved Investigational	AKR1C2	1646	downregulated	dienogest results in decreased expression of AKR1C2 mRNA	10p15.1	A22287
Dienogest	Approved Investigational	CYP19A1	1588	downregulated	dienogest results in decreased expression of CYP19A1 mRNA	15q21.2	A22288
Dienogest	Approved Investigational	HSD17B2	3294	downregulated	dienogest results in decreased expression of HSD17B2 mRNA	16q23.3	A22287
Dienogest	Approved Investigational	PTGS2	5743	downregulated	dienogest results in decreased expression of PTGS2 mRNA	1q31.1	A22288
Diethylstilbestrol	Approved Withdrawn	ABCC3	8714	downregulated	Diethylstilbestrol results in decreased expression of ABCC3 mRNA	17q21.33	A22289
Diethylstilbestrol	Approved Withdrawn	ABHD2	11057	upregulated	Diethylstilbestrol results in increased expression of ABHD2 mRNA	15q26.1	A21106
Diethylstilbestrol	Approved Withdrawn	ACKR2	1238	downregulated	Diethylstilbestrol results in decreased expression of ACKR2 mRNA	3p22.1	A22289
Diethylstilbestrol	Approved Withdrawn	ADAMTS9	56999	upregulated	Diethylstilbestrol results in increased expression of ADAMTS9 mRNA	3p14.1	A22289
Diethylstilbestrol	Approved Withdrawn	ADCY1	107	upregulated	Diethylstilbestrol results in increased expression of ADCY1 mRNA	7p12.3	A22290
Diethylstilbestrol	Approved Withdrawn	ADORA1	134	upregulated	Diethylstilbestrol results in increased expression of ADORA1 mRNA	1q32.1	A22290
Diethylstilbestrol	Approved Withdrawn	AFF3	3899	upregulated	Diethylstilbestrol results in increased expression of AFF3 mRNA	2q11.2	A22289
Diethylstilbestrol	Approved Withdrawn	AKR1B10	57016	upregulated	Diethylstilbestrol results in increased expression of AKR1B10 mRNA	7q33	A20662

Displaying entries 32326 - 32350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability